Blog | Oncotarget

Oncotarget News

Clear Scans Can Be Misleading: Residual Cancer Linked to Worse Outcomes

March 21, 2025

SABR is a well-established therapy in both the curative and metastatic setting, however, its ablative potential may not be as high as suggested by radiographic local control rates.”BUFFALO, NY -... read more

Oncotarget

WIN Consortium Leading the Future of Precision Cancer Medicine

March 18, 2025

Our vision is to accelerate the future of precision oncology care.”BUFFALO, NY - March 18, 2025 – A new precision oncology paper was published in Oncotarget, Volume 16, on March 12,... read more

Oncotarget

Oncotarget to Participate at the AACR Annual Meeting 2025

March 17, 2025

Oncotarget is honored to participate in the American Association for Cancer Research (AACR) Annual Meeting 2025, scheduled for April 25-30 in Chicago.BUFFALO, NY - March 17, 2025 – Impact Journals (Oncotarget’... read more

Oncotarget

Rethinking Breast Cancer Screening: New Insights on Overdiagnosis

March 12, 2025

These suggest that not an insignificant proportion of invasive cancers may also be overdiagnosed as indolent cancers with a very long lead time or cancers that spontaneously regress.”BUFFALO, NY -... read more

Oncotarget

How Environmental Exposures Affect Genes and Increase Cancer Risk

March 11, 2025

Environmental exposures may cause genetic damage, lead to mutations in key genes, and/or block the DNA repair mechanisms increasing the risk of cancer.”BUFFALO, NY - March 11, 2025 – A... read more

Oncotarget

Engineered TIMP Molecules Show Potential to Slow Glioblastoma Brain Cancer Spread

March 3, 2025

Given the lethal nature of GBM and the limited efficacy of current therapies, the application of TIMPs and their engineered minimal variants represents a novel and potentially transformative approach to... read more

Oncotarget

Innovative Biomaterial Accelerates Healing of Chemotherapy-Induced Oral Ulcers in Animal Model

February 25, 2025

To our knowledge, this is the first-in-animal preliminary study, which used a biocompatible electrospun membrane with the addition of autologous cells for ulcerative oral mucositis regeneration.”BUFFALO, NY - February 25,... read more

Oncotarget

Researchers Identify New p53 Targets to Combat Cancer Growth

February 24, 2025

We discovered several novel downstream p53 targets of potential clinical relevance [...]”BUFFALO, NY - February 24, 2025 – A new research paper was published in Oncotarget, Volume 16, on February 18, 2025,... read more

Oncotarget

New Study Suggests Panitumumab with Low-Dose Capecitabine as a Safer, Effective Maintenance Treatment for Advanced Colorectal Cancer

February 18, 2025

Using Panitumumab with metronomic Capecitabine is considered an accepted maintenance regimen in wild type Ras metastatic colorectal cancer regardless of the primary site.”BUFFALO, NY - February 18, 2025 – A new... read more